Back to results
US 11,840,544 B2Granted
Intermediates in the synthesis of C3-substituted cephalosporins
AssigneeNorbrook Laboratories Limited
InventorKarolina Madela
Life of this patent
Estimating the term…
Abstract
Disclosed herein are novel and inventive methods for preparing intermediates in the synthesis of C3-substituted cephalosporins. One preferred C3-substituted cephalosporin of clinical interest is Cefovecin. Accordingly, the present invention provides for methods of preparing reactive halogen intermediates for use in the synthesis of C3-substituted cephalosporins, such as Cefovecin. In the case of Cefovecin the reactive intermediates are of the formula:
Claims12
A method of synthesising a C3-substituted cephalosporin comprising steps of:
- (i) generating a compound of the formula (II) from a compound of the formula (I)
- (ii) reacting the compound of formula (II) with a thiol of the formula (III-1) or (III-2) to yield a compound of the formula (IV-1) or (IV-2), and
- (iii) further processing the compound of formula (IV-1) or (IV-2) to yield a C3-substituted cephalosporin, wherein
- Z is selected from the group consisting of C1-C20 aliphatic, C3-C20 cycloaliphatic, C2-C20 heteroaliphatic, C2-C20 heterocycloaliphatic, C6-C20 aryl, C2-C20 heteroaryl, and combinations thereof;
- X is selected from the group consisting of Cl, Br, and I;
- and
- R11, R12, R13 are the same or different and each of R11, R12, R13 is either H or is independently selected from the group consisting of C1-C20 aliphatic, C3-C20 cycloaliphatic, C2-C20 heteroaliphatic, C2-C20 heterocycloaliphatic, C6-C20 aryl, C2-C20 heteroaryl, and combinations thereof.
4 more elements
Dependencies are inferred from the claim text.